Ignite Creation Date:
2024-05-06 @ 8:59 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02871947
Status:
UNKNOWN
Last Update Posted:
2016-08-18
First Post:
2016-08-16
Brief Title:
Epidemiology and Cytokines Analysis of Severe Asthma Patients in Taiwan
Sponsor:
Taipei Veterans General Hospital Taiwan
Organization:
Taipei Veterans General Hospital Taiwan
Study Overview
Official Title:
Epidemiology and Cytokines Analysis of Severe Asthma Patients in Taiwan
Status:
UNKNOWN
Status Verified Date:
2016-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Severe asthma is a heterogeneous disease characterized by the need for treatment with high doses of inhaled corticosteroids It affects 5-10 of asthmatic patients although it accounts for a significant percentage of the consumption of health care resources Severe asthma comprises various clinical and pathophysiological phenotypes In this current study we aimed to clinical characteristics and cytokes profile in severe asthma patients
Detailed Description:
To investigate the clinical phenotypes and inflammatory endotype by analyzing cytokines in severe asthma patients it may improve characterization of the disease and contribute to improved selection of appropriate treatment It could also help link genotypes with their phenotypic manifestations and their natural history and prognosis A greater understanding of the phenotypes of severe asthma could enable identification of biomarkers for each phenotype and identify the association between biokarkers and clinical outcomes in severe asthma patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None